ArticlePigment cell & melanoma research2026
Polygenic Risk Scores and Its Association With Cutaneous Melanoma Risk in the Swedish Population.
Article in Pigment cell & melanoma research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Polygenic risk scores can quantify an individual's genetic predisposition by combining the effects of multiple gene variants linked to melanoma susceptibility. Previous studies have demonstrated that PRS is strongly associated with melanoma risk and can improve the identification of high-risk individuals beyond that identified by traditional risk factors. The aim of this study was to calculate PRS for melanoma susceptibility in the Swedish population. Sixty-four single nucleotide polymorphisms, previously associated with melanoma susceptibility, were used to calculate PRS for 599 melanoma patients with or without family history of melanoma and 1180 controls. PRS values were significantly higher among melanoma patients than among controls, with an area under the receiver operating characteristic curve of 0.710. Individuals in the highest PRS decile had a fourfold increased melanoma risk compared with those in the 5th-6th decile. PRS was strongly influenced by the pigmentation-related traits skin phototype and hair color, as well as family history of melanoma and, to some extent, the number of primary melanoma tumors. The results show that PRS is strongly associated with melanoma risk in the Swedish population and may serve as a valuable tool for understanding genetic susceptibility and improving risk stratification in melanoma prevention and clinical management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.